Pediatric Cancer | CHOP Research Institute

Pediatric Cancer

The Barakat Lab aims to improve health equity for youth with cancer and their families by designing, evaluating, and implementing developmentally appropriate and accessible assessments and interventions that target medical and psychosocial outcomes across the cancer treatment trajectory.

Published on
Apr 12, 2024
This week, AACR names CHOP physician-scientists as grant recipients, and CIRP researchers publish new findings on driving and mood disorders.
Published on
Mar 25, 2024
Rochelle Bagatell, MD, chaired the multidisciplinary panel that developed the NCCN guidelines, which will help to direct treatment of a highly heterogeneous disease.
Published on
Mar 5, 2024
Two global teams are developing solid cancer drugs and understanding T-cell receptors.
Published on
Jan 29, 2024
With funding from the National Cancer Institute’s Childhood Cancer Data Initiative, CHOP researchers are identifying new immunotherapy targets.

This study involves taking a study drug called venetoclax with or without standard of care chemotherapy.

Published on
Nov 16, 2023
The Connor Initiative, a multimillion dollar gift from the Holveck Family, will support precision therapeutics for osteosarcoma and rare cancers.

The Mitochondria and Cancer Connections (MC2) Research program leverages knowledge from existing centers to establish a novel, cutting-edge research initiative and enable the development of mechanistic understanding and novel therapeutic opportunities at the intersection of mitochondrial disease and pediatric cancer.

Published on
Sep 30, 2022
Learn about novel findings and new grants from Children’s Hospital of Philadelphia researchers.
Published on
Jun 29, 2022
CHOP scientists are part of a Cancer Grand Challenges team receiving $25 million to tackle solid tumors.